Cases & Deals

Roche prevails in patent interference appeal involving human fibroblast and DNA technologies

Clients Hoffman-La Roche Inc.

Jones Day represented Genentech, Inc. and Hoffmann-La Roche Inc. against Japan Foundation for Cancer Research in two appeals of final decisions by the Board of Patent Appeals and Interferences involving recombinant human fibroblast beta interferon and recombinant DNA technologies for producing that interferon in bacteria.

Sugano v. Goeddel

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.